(Q44526972)

3 December 2017

Moxifloxacin for the treatment of patients with complicated intra-abdominal infections (the AIDA Study). (English)

1 reference

3 December 2017

1 reference

G Weiss

1

1 reference

3 December 2017

P Reimnitz

2

1 reference

3 December 2017

B Hampel

3

1 reference

3 December 2017

E Muehlhofer

4

1 reference

3 December 2017

H Lippert

5

1 reference

3 December 2017

AIDA Study Group

6

1 reference

3 December 2017

language of work or name

1 reference

1 April 2009

1 reference

3 December 2017

Journal of Chemotherapy

1 reference

3 December 2017

21

1 reference

3 December 2017

2

1 reference

3 December 2017

170-180

1 reference

Future directions in the management of tertiary peritonitis

3 December 2017

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.2.170

Intensive care unit management of intra-abdominal infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.2.170

The microbiology of postoperative peritonitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.2.170

Critical issues in the clinical management of complicated intra-abdominal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.2.170

Pharmacokinetics and tissue penetration of moxifloxacin in intervention therapy for intra-abdominal abscess

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.2.170

Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.2.170

Moxifloxacin penetration into human gastrointestinal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.2.170

Therapeutic efficacy of moxifloxacin, a new quinolone, in the treatment of experimental intra-abdominal abscesses induced by Bacteroides fragilis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.2.170

A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Cefepime Intra-abdominal Infection Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.2.170

Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial. The Severe Generalized Peritonitis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.2.170

10.1179/JOC.2009.21.2.170

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference